Literature DB >> 8761288

A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer.

M Theile1, S Seitz, W Arnold, B Jandrig, R Frege, P M Schlag, W Haensch, H Guski, K J Winzer, J C Barrett, S Scherneck.   

Abstract

Recent evidence obtained by cytogenetic and molecular studies indicates that in breast cancer chromosome 6q is often affected by genetic changes suggesting the existence of putative tumor suppressor genes (TSGs). However the function of gene(s) on this chromosome in breast cancer suppression is not understood. To substantiate further the presence of breast cancer related TSGs at 6q and to define their location, we first performed microcell-mediated transfer of chromosome 6 to CAL51 breast cancer cells for studying possible suppression of malignant phenotype and secondly, we analysed DNAs from 46 primary breast cancers for loss of constitutive heterozygosity (LOH) using 24 poly-morphic microsatellite markers. The chromosome transfer resulted in loss of tumorigenicity and reversion of other neoplastic properties of the microcell hybrids. Polymorphism analysis of single hybrids revealed that they harbored only a small donor chromosome fragment defined by the marker D6S310 (6q23.3-q25) and flanked by D6S292 and D6S311. The LOH data suggest that four tumor suppressor gene loci mapped to the central and distal portion of 6q may be independently deleted in breast cancer. One of these regions corresponds to the region identified by chromosome transfer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761288

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.

Authors:  Francesco Acquati; Sabrina Bertilaccio; Annalisa Grimaldi; Laura Monti; Raffaella Cinquetti; Paolo Bonetti; Marta Lualdi; Laura Vidalino; Marco Fabbri; Maria Grazia Sacco; Nico van Rooijen; Paola Campomenosi; Davide Vigetti; Alberto Passi; Cristina Riva; Carlo Capella; Francesca Sanvito; Claudio Doglioni; Laura Gribaldo; Paolo Macchi; Antonio Sica; Douglas M Noonan; Paolo Ghia; Roberto Taramelli
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-28       Impact factor: 11.205

2.  Binding assay and preliminary X-ray crystallographic analysis of ACTIBIND, a protein with anticarcinogenic and antiangiogenic activities.

Authors:  Marina de Leeuw; Levava Roiz; Patricia Smirnoff; Betty Schwartz; Oded Shoseyov; Orna Almog
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-28

3.  Genetic prognostic index influences patient outcome for node-positive breast cancer.

Authors:  Shin-Ichi Asaka; Takashi Fujimoto; Junko Akaishi; Kenji Ogawa; Masamitsu Onda
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Thymic epithelial tumors can develop along two different pathogenetic pathways.

Authors:  R Zhou; A Zettl; P Ströbel; K Wagner; H K Müller-Hermelink; S Zhang; A Marx; P Starostik
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

5.  Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.

Authors:  S Hemmer; V M Wasenius; C Haglund; Y Zhu; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

6.  Parkin gene alterations in ovarian carcinoma from northern Indian population.

Authors:  Syed Jafar Mehdi; Asgar Ali; M Moshahid Alam Rizvi
Journal:  Pathol Oncol Res       Date:  2011-01-10       Impact factor: 3.201

7.  Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.

Authors:  S J Mehdi; M S Alam; S Batra; M M A Rizvi
Journal:  Med Oncol       Date:  2010-07-22       Impact factor: 3.064

8.  Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.

Authors:  Catherine J Huntoon; Monica D Nye; Liyi Geng; Kevin L Peterson; Karen S Flatten; Paul Haluska; Scott H Kaufmann; Larry M Karnitz
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

9.  SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer.

Authors:  Xue-Yuan Dong; Carmen Rodriguez; Peng Guo; Xiaodong Sun; Jeffrey T Talbot; Wei Zhou; John Petros; Qunna Li; Robert L Vessella; Adam S Kibel; Victoria L Stevens; Eugenia E Calle; Jin-Tang Dong
Journal:  Hum Mol Genet       Date:  2008-01-17       Impact factor: 6.150

10.  Undetectable and Decreased Expression of KIAA1949 (Phostensin) Encoded on Chromosome 6p21.33 in Human Breast Cancers Revealed by Transcriptome Analysis.

Authors:  Yan A Su; Jun Yang; Lian Tao; Hein Nguyen; Ping He
Journal:  J Cancer       Date:  2010-06-21       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.